Cargando…
Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
PURPOSE: Vincristine is widely used as anticancer therapy for a variety of hematological malignancies. The treatment is limited by progressive vincristine-induced neuropathy, possibly including both peripheral sensory and motor nerves, autonomic nervous functions, and the central nervous system. Thi...
Autores principales: | Madsen, Marie Lindhard, Due, Hanne, Ejskjær, Niels, Jensen, Paw, Madsen, Jakob, Dybkær, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682573/ https://www.ncbi.nlm.nih.gov/pubmed/31214762 http://dx.doi.org/10.1007/s00280-019-03884-5 |
Ejemplares similares
-
Vincristine-Induced Neuropathy in Patients Diagnosed with Solid and Hematological Malignancies: The Role of Dose Rounding
por: Alwhaibi, Abdulrahman M., et al.
Publicado: (2023) -
Vincristine-Induced Cranial Neuropathy
por: TALEBIAN, Ahmad, et al.
Publicado: (2014) -
Vincristine-Induced Peripheral Neuropathy in Children With Malignancy and the Effect of Missed Doses on Treatment Success
por: Eker, Nurşah, et al.
Publicado: (2023) -
Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark
por: Bødker, Julie S., et al.
Publicado: (2020) -
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy
por: Hatzl, Stefan, et al.
Publicado: (2021)